Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 1044Neoplasms 874Prostatic Neoplasms 509Lung Neoplasms 424Colorectal Neoplasms 358Motor Activity 222Head and Neck Neoplasms 195Uterine Cervical Neoplasms 190Carcinoma, Non-Small-Cell Lung 181Brain Neoplasms 175Pancreatic Neoplasms 160Ovarian Neoplasms 140Carcinoma, Hepatocellular 139Colonic Neoplasms 136Anxiety Disorders 125Rectal Neoplasms 117Hematologic Neoplasms 115Multiple Myeloma 106Stomach Neoplasms 102Neoplasm Metastasis 101Melanoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Depression 93Urinary Bladder Neoplasms 89Pain 88Endometrial Neoplasms 87Glioblastoma 85Disease 83Lymphoma 81Sarcoma 79

Interventions

Methotrexate 1Leucovorin 1Dactinomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hydatidiform Mole, Invasive × 1 year × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡